Table 4 Consultation attendance during 2018 and 2022
Consultation modality | 2018 n = 999 (%) | 2019 n = 999 (%) | 2020 n = 999 (%) | 2021 n = 999 (%) | 2022 n = 999 (%) | p-value |
|---|---|---|---|---|---|---|
Telemedicine | 0 (0) | 0 (0) | 105 (10.5) | 5 (0.5) | 5 (0.5) | < 0.001 |
Telephonic | 0 (0) | 899 (90) | 899 (90.0) | 999 (100) | 999 (100) | < 0.001 |
In-person | 999 (100) | 541 (54.2) | 541 (54.2) | 2 (0.2) | 278 (27.8) | < 0.001 |
Specialty consultation attendance during 2018 and 2022 | ||||||
Specialty | 2018 n = 999 (%) | 2019 n = 999 (%) | 2020 n = 999 (%) | 2021 n = 999 (%) | 2022 n = 999 (%) | p-value |
Cardiology | 69 (6.9) | 101 (10.1) | 83 (8.3) | 85 (8.5) | 103 (10.3) | 0.006 |
Diabetes' Education | 274 (27.4) | 246 (24.6) | 125 (12.5) | 72 (7.2) | 90 (9.0) | < 0.001 |
Endocrinology | 85 (8.5) | 91 (9.1) | 99 (9.9) | 108 (10.8) | 121 (12.1) | < 0.001 |
Nephrology | 29 (2.9) | 33 (3.3) | 34 (3.4) | 40 (4.0) | 38 (3.8) | 0.342 |
Neurology | 50 (5.0) | 49 (4.9) | 35 (3.5) | 42 (4.2) | 33 (3.3) | 0.103 |
Nutrition/physical activation | 124 (12.4) | 108 (10.8) | 56 (5.6) | 81 (8.1) | 63 (6.3) | < 0.001 |
Ophthalmology | 474 (47.4) | 507 (50.8) | 285 (28.5) | 355 (35.5) | 369 (36.9) | < 0.001 |
Retinology | 56 (5.6) | 55 (5.5) | 37 (3.7) | 33 (3.3) | 26 (2.6) | < 0.001 |